Eurointervention

Papers
(The TQCC of Eurointervention is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
TAVR under 70: is age just a number?225
International variation in modality and outcomes of left main revascularisation: does it really matter?119
Double-tap to treat paravalvular leak in high-risk annuli99
The conundrum of percutaneous coronary intervention without aspirin: a call for clarity86
In search of the origin of the acronym TAVI75
Transapical transcatheter mitral valve implantation in patients with prior aortic valve replacement: a feasibility report74
Transcatheter left ventriculoplasty74
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis66
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation s58
Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis57
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort study54
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry50
Recanalisation of coronary chronic total occlusions49
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement47
Transcatheter edge-to-edge repair with the PASCAL device for failed MitraClip procedure46
Defer-based non-stenting: a promising approach for STEMI45
A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarc43
Incidence and mechanisms of bioprosthetic dysfunction after transcatheter implantation of a mechanically-expandable heart valve42
Thermodilution-derived temperature recovery time: a novel predictor of microvascular reperfusion and prognosis after myocardial infarction41
Hybrid coronary revascularisation: the best or the worst of both worlds?41
   Atrial fibrillation and acute coronary syndrome 40
The “road travelled”: reflections on the transformation of information exchange in a digital age40
One-month DAPT after acute coronary syndrome: too short or not too short?38
Transcatheter edge-to-edge valve repair versus minimally invasive beating-heart surgery of the tricuspid valve: an observational study37
Twelve-month outcomes of the LuX-Valve for transcatheter treatment of severe tricuspid regurgitation36
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document36
Redo transcatheter mitral valve replacement in mitral annular calcification35
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection35
Early outcomes of transcatheter versus surgical aortic valve implantation in patients with bicuspid aortic valve stenosis32
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial32
Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes31
Invasive functional testing in the cath lab as a routine investigation in INOCA: pros and cons30
Impact of off-hours admissions in STEMI-related cardiogenic shock managed with microaxial flow pump – insights from J-PVAD29
A novel robotic radiation shielding device for interventional cardiology procedures28
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-yearresults of the ACURATE neo2 PMCF Study28
Comparison of acute thrombogenicity and albumin adsorption in three different durable polymer coronary drug-eluting stents28
Geographical variations in left main coronary artery revascularisation: a prespecified analysis of the EXCEL trial28
Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacement27
Chordal replacement and annuloplasty in one transfemoral device for degenerative mitral regurgitation27
A novel three-dimensional imaging approach to evaluate coronary access before transcatheter aortic valve-in-valve implantation27
Oesophageal and gastric injuries caused by transoesophageal probe manipulation in patients undergoing transcatheter edge-to-edge repair for tricuspid regurgitation26
Antithrombotic therapy for transcatheter structural heart intervention26
Percutaneous versus surgical transaxillary access for transcatheter aortic valve replacement: a propensity-matched analysis of the US experience25
Prevalence and outcomes of stent thrombosis with in-stent calcified nodules: substudy from the REAL-ST registry25
Device entrapment during percutaneous coronary intervention of chronic total occlusions: incidence and management strategies25
Cerebral embolic protection during transcatheter heart interventions25
Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the ra25
Thirty-day outcomes of the Cardioband tricuspid system for patients with symptomatic functional tricuspid regurgitation: The TriBAND study24
A nationwide analysis of reperfusion therapies for pulmonary embolism in older patients with frailty24
Management of cardiogenic shock24
Coronary lithotripsy for the treatment of underexpanded stents: the international multicentre CRUNCH registry23
Early outcomes of transcatheter mitral valve replacement with the Tendyne system in severe mitral annular calcification23
ACURATE neo2 versus SAPIEN 3 Ultra for transcatheter aortic valve implantation22
SYNTAXES, biomarkers and survival in complex coronary artery disease: the intervention of secondary prevention21
Shifting focus in bifurcations.21
Optical coherence tomography to visualise the endothelialisation of left atrial appendage occluders21
Delayed hospitalisation for heart failure after transcatheter repair or medical treatment for secondary mitral regurgitation: a landmark analysis of the MITRA-FR trial21
Prevention of left ventricular outflow tract obstruction in transapical mitral valve replacement: the MitraCut procedure20
TAVI patients with bystander coronary artery disease should receive PCI: pros and cons20
Procedural and early outcomes of transcatheter edge-to-edge mitral valve repair in very elderly patients19
Is transcatheter aortic valve implantation safe in patients with left ventricular outflow tract calcification?19
Determinants of adverse outcomes following patent foramen ovale closure in elderly patients19
Acute and one-year clinical outcomes of pre-stenting intravascular ultrasound: a patient-level meta-analysis of randomised clinical trials19
New-onset atrial fibrillation detected by ambulatory ECG monitoring after transcatheter aortic valve implantation19
UNICA − a novel single-stent, double-valve, heterotopic, cross-caval approach for severe tricuspid insufficiency 19
Coronary CT as a first-line investigation in chronic coronary syndromes: pros and cons18
The ongoing conundrum of the best care for patients presenting with non-ST-segment elevation acute coronary syndrome18
Supporting evidence for ST-segment elevation myocardial infarction from optical coherence tomography17
Ticagrelor-based antiplatelet therapy after percutaneous coronary intervention in chronic coronary syndrome17
Near-infrared spectroscopy to predict plaque progression in plaque-free artery regions17
Safety of absolute coronary flow and microvascular resistance measurements by thermodilution17
The patent foramen ovale does not spontaneously close in patients aged 6017
Robotics, imaging, and artificial intelligence in the catheterisation laboratory17
Diagnostic accuracy of quantitative flow ratio in patients with arrhythmias16
Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis16
Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?16
Predictors and clinical impact of worsening left ventricular ejection fraction after mitral transcatheter edge-to-edge repair16
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation16
Targeting inflammation in atherosclerosis: overview, strategy and directions16
Three-year outcomes of transcatheter aortic valve implantation for bicuspid versus tricuspid aortic stenosis16
Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI15
Direct oral anticoagulants for ventricular thrombus resolution: pilot trials show reassuring efficacy and safety compared to warfarin15
Low-dose fibrinolysis during primary percutaneous intervention for preventing no-reflow: stepping back to move forward?15
SAPIEN 3 Ultra: better sealing, reduced paravalvular leak and a move in the right direction?15
Left atrial appendage closure for thrombus trapping: the international, multicentre TRAPEUR registry15
Anterior mitral leaflet modification with endoscopic scissors during Tendyne implantation15
Stent underexpansion in the CRUNCH registry: worth cracking?15
Predictors and prognostic relevance of tricuspid alterations in patients undergoing transcatheter edge-to-edge mitral valve repair14
Clinical outcomes of transcatheter mitral valve replacement: two-year results of the CHOICE-MI Registry14
Letter: Caffeine and fractional flow reserve overestimation: a word of caution14
PCR London Valves - in person or online - an invaluable opportunity for exchange dedicated to advancing the treatment of valvular heart disease14
EuroIntervention: the 200th issue14
Procedural considerations for transcatheter aortic valve-in-valve implantation in a degenerated ACURATE neo prosthesis14
Reply: Spontaneous coronary artery dissection in France13
Vessel fractional flow reserve (vFFR) for the assessment of stenosis severity: the FAST II study13
Combined functional and anatomical assessment of coronary stenosis by coronary CT angiography13
We now have enough evidence to support systematic OCT in daily PCI practice: pros and cons13
Severely calcified coronary stenoses: a war or a battle?13
0.20284199714661